SCHEMBL3245420

SCHEMBL3245420

O=C(O)c1ccc(Cn2nc(-c3cc(Cl)cc(Cl)c3)cc2-c2nc3ccccc3s2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 12/20 0.52
GIPR P48546 5/20 0.52
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP2C9 P11712 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C8 P10632 1/20 0.44
KCNH2 Q12809 1/20 0.44
AKR1B1 P15121 1/20 0.44
HSF1 Q00613 1/20 0.43
NOX4 Q9NPH5 1/20 0.43
PTGER4 P35408 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ATM Q13315 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4370596 0.80 GCGR (0.66) GCGRGIPRCYP2C9CYP3A4CYP2C8
SCHEMBL2667870 0.79 GCGR (0.67) GCGRGIPRCYP2C9CYP3A4CYP2C8
SCHEMBL2667521 0.78 GCGR (0.64) GCGRGIPRCYP2C9CYP3A4CYP2C8
SCHEMBL2249206 0.78 GCGR (0.53) GCGRGIPRCYP2C9CYP3A4CYP2C8
SCHEMBL3257089 0.76 GCGR (0.75) GCGRGIPRCYP2C9CYP3A4CYP2C8
SCHEMBL2667502 0.75 GCGR (0.64) GCGRGIPRCYP2C9CYP3A4CYP2C8
SCHEMBL2252981 0.75 GCGR (0.64) GCGRGIPRCYP2C9CYP3A4CYP2C8
SCHEMBL2257761 0.73 GCGR (0.61) GCGRGIPRCYP2C9CYP3A4CYP2C8
SCHEMBL505728 0.72 KDM4E (0.69) KDM4ELMNANFKB1NFKB2RELA
SCHEMBL2253902 0.69 GCGR (0.83) GCGRGIPRCYP2C9CYP3A4CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773330-B1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK SHARP & DOHME (US) 2010-05-26 EP disclosed
US-7625938-B2 Substituted pyrazoles, compositions containing such compounds and methods of use MERCK & CO., INC. (US) 2009-12-01 US disclosed
US-20080108620-A1 Substituted Pyrazoles, Compositions Containing such Compounds and Methods of Use MERCK & CO., INC. (US) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108620-A1 Substituted Pyrazoles, Compositions Containing such Compounds and Methods of Use GLP1R, GCGR, GPR119 GCGR 2/4885GIPR 4/4885KDM4E 3476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.